Sphere Corp.
KKRX:34770020,000.00
KRW
-650.00
(-3.15%)
ISIN
KR7347700007
Return %
Stock
S&P 500
1Y
113.90
14.39
3Y
601.91
81.42
5Y
112.84
68.62
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Kwang-Soo Choi
- Full Time Employees
- 34
- Sector
- Technology services
- Industry
- Packaged software
- Address
- Yeongchang Building Seoul SL South Korea
- IPO Date
- Mar 23, 2021
- Website
- spherecorp.kr
- Similar Companies
- Business
- Sphere Corp. operates as a digital health and life care technology company delivering integrated patient data platforms and digital health services. Founded in 2023 and headquartered in Seoul, Sphere Corp. develops LifeRecord, a commercial personal health record platform that aggregates medical records, genome data, and user-generated health data, and offers digital healthcare services that include non-face-to-face treatment, medication management, and ongoing health management; it also supports patient communities with digital health enablement, incorporating digital therapeutics and software-based medical devices powered by artificial intelligence. Main products and services - LifeRecord platform: a comprehensive personal health record system that aggregates medical histories, genomic data, and user-generated health data; supports data portability, interoperability with healthcare providers, and secure sharing controls. - Digital health services for consumers: non-face-to-face treatment capabilities, remote medication management, adherence support, and chronic disease management programs. - Digital therapeutics: software-driven therapeutic interventions designed to prevent, manage, or treat medical conditions, delivered via mobile and web interfaces. - Software-based medical devices and AI-enabled health tools: AI-powered apps and devices that assist clinical decision support, risk stratification, and personalized health recommendations. - Patient communities and digital health enablement: platforms that facilitate peer support, education, and engagement around health management. - Data analytics and health insights: value-added services leveraging health data, genomic information, and real-world evidence to inform care decisions and potential partnerships. Latest major company changes - Strategic focus on expanded digital health platforms and AI-enabled tools to enhance patient engagement and care coordination. - Potential partnerships or collaborations to scale LifeRecord interoperability with healthcare providers and payers. - Ongoing product enhancements to LifeRecord and companion digital health services, including updates to AI-driven clinical support features. - Geographic expansion initiatives targeting additional markets in Asia and Europe through partnerships and local operations. - Structural or branding refinements aligned with the broader objective of integrating health data management, digital therapeutics, and remote care services. Additional context - Industry and segments: digital health technology; personal health records; digital therapeutics; AI-enabled medical devices; remote care and medication management; health data analytics. - Target markets: healthcare providers, payers, life sciences partners, and individual consumers seeking integrated digital health solutions. - Geographic operations: Korea (headquarters), with potential activity in other Asian markets and Europe as part of growth initiatives. - Corporate relationships: operates as an independent entity; potential collaboration or alignment with affiliated health technology ventures or research partnerships.